Sanofi, Beijing and insulin

Sanofi Unveils $1 Billion China Investment to Boost Production
Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest single investment in China to date and part of a broader push to boost manufacturing capacity in Asia.
Sanofi to invest $1 billion in insulin production site in Beijing, local authority says
French drugmaker Sanofi plans to invest 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, a local authority in the city said on Monday, citing a memorandum of understanding the company signed with an economic zone.
Sanofi to invest in new insulin production base in Beijing
French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in Beijing, according to the Beijing Economic-Technological Development Area (BDA).
China welcomes new US$1 billion Sanofi project in Beijing
Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.
Sanofi announces its largest China investment amid ongoing trade war
The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer on.
Sanofi to Invest $1.05 Billion in New Insulin Manufacturing Base in China
The new base, which will be located in Yizhuang, Beijing, marks Sanofi’s second production site in the capital and its fourth in the country.
Sanofi to build $1 billion insulin production base in China
Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people in the mainland, nearly 12% of its population, had the illness as of 2021,
Sanofi invests 1 bln euros in Beijing to expand insulin production
Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health
Sanofi punts 1 billion euros on new insulin production base in China
The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing Municipal Bureau of Economy and Information Technology and Beijing Economic and Technological Development Zone today to invest around 1 billion euros ($1.
Sanofi To Invest $1.05 Bln For New Insulin Production Base In China
French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in
academy1h
China's First International Pharma
The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...
STAT20h
Sanofi pours $1 billion into China for insulin plant
Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...